We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDM68IG TIDMMDC
RNS Number : 8082A
Standard Bank Group Limited
26 May 2023
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: * Standard Bank of South Africa Limited * SBG Securities (Pty) Ltd (b) Name of offeror/offeree in relation to whose relevant securities Mediclinic International Plc this form relates: Use a separate form for each offeror/offeree --------------------------------------------- (c) Name of the party to the offer with which exempt principal trader Mediclinic International Plc is connected: --------------------------------------------- (d) Date position held/dealing undertaken: 25 May 2023 For an opening position disclosure, state the latest practicable date prior to the disclosure --------------------------------------------- (e) In addition to the company in 1(b) above, is the exempt principal N/A trader making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" --------------------------------------------- 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 10p ordinary Interests Short positions ---------------- ------------------ Number % Number % -------- ------ ---------- ------ (1) Relevant securities owned and/or controlled: 208 574 0.028 -------- ------ ---------- ------ (2) Cash-settled derivatives: 208 574 0.028 -------- ------ ---------- ------ (3) Stock-settled derivatives (including options) and agreements to purchase/sell: -------- ------ ---------- ------ TOTAL*: 208 574 0.028 208 574 0.028 -------- ------ ---------- ------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options) Class of relevant security in relation to which subscription right exists: None Details, including nature of the rights concerned and relevant percentages: None ----- 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales Class of relevant Purchases/ sales Total number of Highest price per Lowest price per unit security securities unit paid/received paid/received (ZAR) (ZAR) 10p ordinary MEI:SJ Purchase 36 639 118,46 117,96 ------------------ ----------------------- ---------------------- ----------------------- 10p ordinary MEI:SJ Sale -24 590 118,30 117,99 ------------------ ----------------------- ---------------------- ----------------------- (b) Cash-settled derivative transactions Class of relevant Product description Nature of dealing Number of reference Price per unit security e.g. CFD e.g. opening/closing a securities (ZAR) long/short position, (ZAR) increasing/reducing a long/short position Short Position 10p ordinary MEI:SJ CFD Increasing -35 036 118,20 --------------------- ------------------------- ------------------------ --------------- Short Position 10p ordinary MEI:SJ CFD Decreasing 22 987 118,25 --------------------- ------------------------- ------------------------ --------------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry date Option money relevant description purchasing, securities price per e.g. paid/ security e.g. call selling, to which unit American, received per option varying etc. option European unit relates etc. (ii) Exercise Class of relevant Product description Exercising/ exercised Number of securities Exercise price per security e.g. call option against unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing Details Price per unit (if applicable) e.g. subscription, conversion 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? No Date of disclosure: 26 May 2023 Contact name: SBSA Global Markets Compliance ------------------------------- Telephone number: +27 11 415 4465 -------------------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .
, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FEOUNUWROVUVURR
(END) Dow Jones Newswires
May 26, 2023 04:29 ET (08:29 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions